{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:28:25Z","timestamp":1792708105972,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["FJC2018-035755-I"],"award-info":[{"award-number":["FJC2018-035755-I"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["RYC-2015-17065"],"award-info":[{"award-number":["RYC-2015-17065"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["575264"],"award-info":[{"award-number":["575264"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2016-75500-R"],"award-info":[{"award-number":["SAF2016-75500-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-109033RB-I00"],"award-info":[{"award-number":["PID2019-109033RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS-PI19\/01746"],"award-info":[{"award-number":["FIS-PI19\/01746"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The chronic inflammatory process that characterizes inflammatory bowel diseases (IBD) is mainly driven by T-cell response to microbial and environmental antigens. Psychological stress is a potential trigger of clinical flares of IBD, and sphingosine-1-phosphate (S1P) is involved in T-cell recruitment. Hence, stress impact and the absence of sphingosine kinase 2 (Sphk2), an enzyme of S1P metabolism, were evaluated in the colon of mice after sub-chronic stress exposure. Here, we show that sub-chronic stress increased S1P in the mouse colon, possibly due to a decrease in its degradation enzymes and Sphk2. S1P accumulation could lead to inflammation and immune dysregulation reflected by upregulation of toll-like receptor 4 (TLR4) pathway, inhibition of anti-inflammatory mechanisms, cytokine-expression profile towards a T-helper lymphocyte 17 (Th17) polarization, plasmacytosis, decrease in IgA+ lymphoid lineage cells (CD45+)\/B cells\/plasmablasts, and increase in IgM+\u2009B cells. Stress also enhanced intestinal permeability. Sphk2 knockout mice presented a cytokine-expression profile towards a boosted Th17 response, lower expression of claudin 3,4,7,8, and structural abnormalities in the colon. Intestinal pathophysiology should consider stress and S1P as modulators of the immune response. S1P-based drugs, including Sphk2 potentiation, represent a promising approach to treat IBD.<\/jats:p>","DOI":"10.1038\/s41598-022-08011-8","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T11:04:59Z","timestamp":1646737499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon inflammation induced by sub-chronic stress"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0195-2604","authenticated-orcid":false,"given":"David","family":"Mart\u00edn-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7599-5346","authenticated-orcid":false,"given":"Irene L.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0244-0259","authenticated-orcid":false,"given":"Marta","family":"Gonz\u00e1lez-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1527-8895","authenticated-orcid":false,"given":"Karina S.","family":"MacDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-3452","authenticated-orcid":false,"given":"Javier","family":"Robledo-Monta\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-8479","authenticated-orcid":false,"given":"Hiram","family":"Tendilla-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Calleja-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-3755","authenticated-orcid":false,"given":"\u00c1lvaro G.","family":"Bris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1322-644X","authenticated-orcid":false,"given":"Cristina","family":"Ulecia-Mor\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-749X","authenticated-orcid":false,"given":"Javier R.","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-1530","authenticated-orcid":false,"given":"Borja","family":"Garc\u00eda-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4192-7382","authenticated-orcid":false,"given":"Sandra","family":"Rodrigues-Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5424-2484","authenticated-orcid":false,"given":"Ignacio","family":"Mar\u00edn-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9901-0094","authenticated-orcid":false,"given":"Juan Carlos","family":"Leza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-3726","authenticated-orcid":false,"given":"Luis","family":"Mench\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"8011_CR1","doi-asserted-by":"publisher","first-page":"104835","DOI":"10.1016\/j.phrs.2020.104835","volume":"158","author":"M Leppkes","year":"2020","unstructured":"Leppkes, M. & Neurath, M. F. Cytokines in inflammatory bowel diseases\u2014Update 2020. Pharmacol. Res. 158, 104835. https:\/\/doi.org\/10.1016\/j.phrs.2020.104835 (2020).","journal-title":"Pharmacol. Res."},{"key":"8011_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00385-2","author":"B Niesler","year":"2021","unstructured":"Niesler, B., Kuerten, S., Demir, I. E. & Sch\u00e4fer, K. H. Disorders of the enteric nervous system\u2014A holistic view. Nat. Rev. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1038\/s41575-020-00385-2 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"8011_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.gtc.2017.08.006","volume":"46","author":"CN Bernstein","year":"2017","unstructured":"Bernstein, C. N. The brain\u2013gut axis and stress in inflammatory bowel disease. Gastroenterol. Clin. N. Am. 46, 839\u2013846. https:\/\/doi.org\/10.1016\/j.gtc.2017.08.006 (2017).","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"8011_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ajg.2015.147","volume":"110","author":"LE Targownik","year":"2015","unstructured":"Targownik, L. E. et al. The relationship among perceived stress, symptoms, and inflammation in persons with inflammatory bowel disease. Am. J. Gastroenterol. 110, 1001\u20131012. https:\/\/doi.org\/10.1038\/ajg.2015.147 (2015) (quiz 1013).","journal-title":"Am. J. Gastroenterol."},{"key":"8011_CR5","doi-asserted-by":"publisher","first-page":"e0233365","DOI":"10.1371\/journal.pone.0233365","volume":"15","author":"M Araki","year":"2020","unstructured":"Araki, M. et al. Psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter cross-sectional study. PLoS ONE 15, e0233365. https:\/\/doi.org\/10.1371\/journal.pone.0233365 (2020).","journal-title":"PLoS ONE"},{"key":"8011_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/s2468-1253(20)30188-6","volume":"5","author":"BG Feagan","year":"2020","unstructured":"Feagan, B. G. et al. Ozanimod induction therapy for patients with moderate to severe Crohn\u2019s disease: A single-arm, phase 2, prospective observer-blinded endpoint study. Lancet Gastroenterol. Hepatol. 5, 819\u2013828. https:\/\/doi.org\/10.1016\/s2468-1253(20)30188-6 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"8011_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.yexmp.2014.07.013","volume":"97","author":"C Wang","year":"2014","unstructured":"Wang, C. et al. Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues. Exp. Mol. Pathol. 97, 259\u2013265. https:\/\/doi.org\/10.1016\/j.yexmp.2014.07.013 (2014).","journal-title":"Exp. Mol. Pathol."},{"key":"8011_CR8","doi-asserted-by":"publisher","first-page":"107464","DOI":"10.1016\/j.pharmthera.2019.107464","volume":"207","author":"OA Sukocheva","year":"2020","unstructured":"Sukocheva, O. A. et al. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacol. Ther. 207, 107464. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107464 (2020).","journal-title":"Pharmacol. Ther."},{"key":"8011_CR9","doi-asserted-by":"publisher","first-page":"109875","DOI":"10.1016\/j.cellsig.2020.109875","volume":"79","author":"FN Velazquez","year":"2021","unstructured":"Velazquez, F. N. et al. Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid. Cell. Signal. 79, 109875. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109875 (2021).","journal-title":"Cell. Signal."},{"key":"8011_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3389\/fphar.2019.00807","volume":"10","author":"S Grassi","year":"2019","unstructured":"Grassi, S. et al. Sphingosine 1-phosphate receptors and metabolic enzymes as druggable targets for brain diseases. Front. Pharmacol. 10, 807. https:\/\/doi.org\/10.3389\/fphar.2019.00807 (2019).","journal-title":"Front. Pharmacol."},{"key":"8011_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1124\/jpet.115.225862","volume":"355","author":"Y Kharel","year":"2015","unstructured":"Kharel, Y. et al. Sphingosine kinase 2 inhibition and blood sphingosine 1-phosphate levels. J. Pharmacol. Exp. Ther. 355, 23\u201331. https:\/\/doi.org\/10.1124\/jpet.115.225862 (2015).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"8011_CR12","doi-asserted-by":"publisher","first-page":"e53521","DOI":"10.1371\/journal.pone.0053521","volume":"8","author":"AJ Snider","year":"2013","unstructured":"Snider, A. J., Ruiz, P., Obeid, L. M. & Oates, J. C. Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis. PLoS ONE 8, e53521. https:\/\/doi.org\/10.1371\/journal.pone.0053521 (2013).","journal-title":"PLoS ONE"},{"key":"8011_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ccr.2012.11.013","volume":"23","author":"J Liang","year":"2013","unstructured":"Liang, J. et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 23, 107\u2013120. https:\/\/doi.org\/10.1016\/j.ccr.2012.11.013 (2013).","journal-title":"Cancer Cell"},{"key":"8011_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.14670\/hh-11-939","volume":"33","author":"DD Song","year":"2018","unstructured":"Song, D. D., Zhou, J. H. & Sheng, R. Regulation and function of sphingosine kinase 2 in diseases. Histol. Histopathol. 33, 433\u2013445. https:\/\/doi.org\/10.14670\/hh-11-939 (2018).","journal-title":"Histol. Histopathol."},{"key":"8011_CR15","doi-asserted-by":"publisher","first-page":"G565","DOI":"10.1152\/ajpgi.00158.2011","volume":"302","author":"S Zoppi","year":"2012","unstructured":"Zoppi, S. et al. Endogenous cannabinoid system regulates intestinal barrier function in vivo through cannabinoid type 1 receptor activation. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G565-571. https:\/\/doi.org\/10.1152\/ajpgi.00158.2011 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"8011_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.imlet.2011.10.006","volume":"141","author":"SC Diesner","year":"2012","unstructured":"Diesner, S. C. et al. Sphingosine-kinase 1 and 2 contribute to oral sensitization and effector phase in a mouse model of food allergy. Immunol. Lett. 141, 210\u2013219. https:\/\/doi.org\/10.1016\/j.imlet.2011.10.006 (2012).","journal-title":"Immunol. Lett."},{"key":"8011_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/jci40659","volume":"120","author":"A Olivera","year":"2010","unstructured":"Olivera, A. et al. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J. Clin. Investig. 120, 1429\u20131440. https:\/\/doi.org\/10.1172\/jci40659 (2010).","journal-title":"J. Clin. Investig."},{"key":"8011_CR18","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.ajpath.2018.08.016","volume":"188","author":"DC Montrose","year":"2018","unstructured":"Montrose, D. C. et al. Colonoscopic-guided pinch biopsies in mice as a useful model for evaluating the roles of host and luminal factors in colonic inflammation. Am. J. Pathol. 188, 2811\u20132825. https:\/\/doi.org\/10.1016\/j.ajpath.2018.08.016 (2018).","journal-title":"Am. J. Pathol."},{"key":"8011_CR19","doi-asserted-by":"publisher","first-page":"65588","DOI":"10.18632\/oncotarget.19514","volume":"8","author":"M Adamiak","year":"2017","unstructured":"Adamiak, M. et al. Mobilization studies in mice deficient in sphingosine kinase 2 support a crucial role of the plasma level of sphingosine-1-phosphate in the egress of hematopoietic stem progenitor cells. Oncotarget 8, 65588\u201365600. https:\/\/doi.org\/10.18632\/oncotarget.19514 (2017).","journal-title":"Oncotarget"},{"key":"8011_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1096\/fj.08-118109","volume":"23","author":"AJ Snider","year":"2009","unstructured":"Snider, A. J. et al. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J. 23, 143\u2013152. https:\/\/doi.org\/10.1096\/fj.08-118109 (2009).","journal-title":"FASEB J."},{"key":"8011_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/mi.2016.35","volume":"10","author":"T Karuppuchamy","year":"2017","unstructured":"Karuppuchamy, T. et al. Sphingosine-1-phosphate receptor-1 (S1P(1)) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease. Mucosal Immunol. 10, 162\u2013171. https:\/\/doi.org\/10.1038\/mi.2016.35 (2017).","journal-title":"Mucosal Immunol."},{"key":"8011_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.lfs.2018.11.026","volume":"215","author":"R Rida","year":"2018","unstructured":"Rida, R. & Kreydiyyeh, S. FTY720P inhibits the Na(+)\/K(+) ATPase in Caco-2 cells via S1PR2: PGE2 and NO are along the signaling pathway. Life Sci. 215, 198\u2013206. https:\/\/doi.org\/10.1016\/j.lfs.2018.11.026 (2018).","journal-title":"Life Sci."},{"key":"8011_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.09.026","author":"S Igawa","year":"2020","unstructured":"Igawa, S. et al. Sphingosine 1-phosphate receptor 2 is central to maintaining epidermal barrier homeostasis. J. Investig. Dermatol. https:\/\/doi.org\/10.1016\/j.jid.2020.09.026 (2020).","journal-title":"J. Investig. Dermatol."},{"key":"8011_CR24","doi-asserted-by":"publisher","first-page":"111116","DOI":"10.1016\/j.biopha.2020.111116","volume":"134","author":"SL Qu","year":"2021","unstructured":"Qu, S. L. et al. Suppression of Th17 cell differentiation via sphingosine-1-phosphate receptor 2 by cinnamaldehyde can ameliorate ulcerative colitis. Biomed. Pharmacother. 134, 111116. https:\/\/doi.org\/10.1016\/j.biopha.2020.111116 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"8011_CR25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nature06663","volume":"452","author":"F Niessen","year":"2008","unstructured":"Niessen, F. et al. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452, 654\u2013658. https:\/\/doi.org\/10.1038\/nature06663 (2008).","journal-title":"Nature"},{"key":"8011_CR26","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1164\/rccm.201701-0241OC","volume":"196","author":"J Hou","year":"2017","unstructured":"Hou, J. et al. S1PR3 signaling drives bacterial killing and is required for survival in bacterial sepsis. Am. J. Respir. Crit. Care Med. 196, 1559\u20131570. https:\/\/doi.org\/10.1164\/rccm.201701-0241OC (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"8011_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/01.mib.0000161305.81198.0f","volume":"11","author":"LE Oostenbrug","year":"2005","unstructured":"Oostenbrug, L. E. et al. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm. Bowel Dis. 11, 567\u2013575. https:\/\/doi.org\/10.1097\/01.mib.0000161305.81198.0f (2005).","journal-title":"Inflamm. Bowel Dis."},{"key":"8011_CR28","doi-asserted-by":"publisher","first-page":"607891","DOI":"10.3389\/fimmu.2020.607891","volume":"11","author":"L Suarez-Lopez","year":"2020","unstructured":"Suarez-Lopez, L. et al. MAPKAP kinase-2 drives expression of angiogenic factors by tumor-associated macrophages in a model of inflammation-induced colon cancer. Front. Immunol. 11, 607891. https:\/\/doi.org\/10.3389\/fimmu.2020.607891 (2020).","journal-title":"Front. Immunol."},{"key":"8011_CR29","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1073\/pnas.1617290114","volume":"114","author":"T Gobbetti","year":"2017","unstructured":"Gobbetti, T. et al. Protectin D1(n-3 DPA) and resolvin D5(n-3 DPA) are effectors of intestinal protection. Proc. Natl. Acad. Sci. USA. 114, 3963\u20133968. https:\/\/doi.org\/10.1073\/pnas.1617290114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"8011_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab034","author":"J Miranda-Bautista","year":"2021","unstructured":"Miranda-Bautista, J. et al. Liver X receptor exerts anti-inflammatory effects in colonic epithelial cells via ABCA1 and its expression is decreased in human and experimental inflammatory bowel disease. Inflamm. Bowel Dis. https:\/\/doi.org\/10.1093\/ibd\/izab034 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"8011_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nmo.12706","volume":"28","author":"JW Wiley","year":"2016","unstructured":"Wiley, J. W., Higgins, G. A. & Athey, B. D. Stress and glucocorticoid receptor transcriptional programming in time and space: Implications for the brain-gut axis. Neurogastroenterol. Motil. 28, 12\u201325. https:\/\/doi.org\/10.1111\/nmo.12706 (2016).","journal-title":"Neurogastroenterol. Motil."},{"key":"8011_CR32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1124\/mol.117.108381","volume":"92","author":"H Wakita","year":"2017","unstructured":"Wakita, H., Yanagawa, T., Kuboi, Y. & Imai, T. E6130, a novel CX3C chemokine receptor 1 (CX3CR1) modulator, attenuates mucosal inflammation and reduces CX3CR1(+) leukocyte trafficking in mice with colitis. Mol. Pharmacol. 92, 502\u2013509. https:\/\/doi.org\/10.1124\/mol.117.108381 (2017).","journal-title":"Mol. Pharmacol."},{"key":"8011_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab032","author":"S Verstockt","year":"2021","unstructured":"Verstockt, S. et al. Oncostatin M is a biomarker of diagnosis, worse disease prognosis, and therapeutic nonresponse in inflammatory bowel disease. Inflamm. Bowel Dis. https:\/\/doi.org\/10.1093\/ibd\/izab032 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"8011_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nm.4307","volume":"23","author":"NR West","year":"2017","unstructured":"West, N. R. et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat. Med. 23, 579\u2013589. https:\/\/doi.org\/10.1038\/nm.4307 (2017).","journal-title":"Nat. Med."},{"key":"8011_CR35","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1084\/jem.20111453","volume":"209","author":"M Coccia","year":"2012","unstructured":"Coccia, M. et al. IL-1\u03b2 mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J. Exp. Med. 209, 1595\u20131609. https:\/\/doi.org\/10.1084\/jem.20111453 (2012).","journal-title":"J. Exp. Med."},{"key":"8011_CR36","doi-asserted-by":"publisher","first-page":"eaaw2262","DOI":"10.1126\/sciimmunol.aaw2262","volume":"5","author":"SN Harbour","year":"2020","unstructured":"Harbour, S. N. et al. T(H)17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci. Immunol. 5, eaaw2262. https:\/\/doi.org\/10.1126\/sciimmunol.aaw2262 (2020).","journal-title":"Sci. Immunol."},{"key":"8011_CR37","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","volume":"50","author":"M Friedrich","year":"2019","unstructured":"Friedrich, M., Pohin, M. & Powrie, F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity 50, 992\u20131006. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.017 (2019).","journal-title":"Immunity"},{"key":"8011_CR38","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature13577","volume":"513","author":"C Schiering","year":"2014","unstructured":"Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564\u2013568. https:\/\/doi.org\/10.1038\/nature13577 (2014).","journal-title":"Nature"},{"key":"8011_CR39","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/ibd\/izz011","volume":"25","author":"HR Wardill","year":"2019","unstructured":"Wardill, H. R. et al. Acute colitis drives tolerance by persistently altering the epithelial barrier and innate and adaptive immunity. Inflamm. Bowel Dis. 25, 1196\u20131207. https:\/\/doi.org\/10.1093\/ibd\/izz011 (2019).","journal-title":"Inflamm. Bowel Dis."},{"key":"8011_CR40","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ni.2730","volume":"14","author":"CS Garris","year":"2013","unstructured":"Garris, C. S. et al. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat. Immunol. 14, 1166\u20131172. https:\/\/doi.org\/10.1038\/ni.2730 (2013).","journal-title":"Nat. Immunol."},{"key":"8011_CR41","doi-asserted-by":"publisher","first-page":"594","DOI":"10.2340\/00015555-3160","volume":"99","author":"SH Shin","year":"2019","unstructured":"Shin, S. H. et al. Inhibiting sphingosine kinase 2 derived-sphingosine-1-phosphate ameliorates psoriasis-like skin disease via blocking Th17 differentiation of na\u00efve CD4 T lymphocytes in mice. Acta Derm. Venereol. 99, 594\u2013601. https:\/\/doi.org\/10.2340\/00015555-3160 (2019).","journal-title":"Acta Derm. Venereol."},{"key":"8011_CR42","doi-asserted-by":"publisher","first-page":"13233","DOI":"10.1038\/s41598-018-31666-1","volume":"8","author":"G Barra","year":"2018","unstructured":"Barra, G. et al. Sphingosine Kinases promote IL-17 expression in human T lymphocytes. Sci. Rep. 8, 13233. https:\/\/doi.org\/10.1038\/s41598-018-31666-1 (2018).","journal-title":"Sci. Rep."},{"key":"8011_CR43","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1172\/jci125297","volume":"130","author":"CJ Studstill","year":"2020","unstructured":"Studstill, C. J. et al. Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence. J. Clin. Investig. 130, 6523\u20136538. https:\/\/doi.org\/10.1172\/jci125297 (2020).","journal-title":"J. Clin. Investig."},{"key":"8011_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro, F. et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J. Crohns Colitis 11, 649\u2013670. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx008 (2017).","journal-title":"J. Crohns Colitis"},{"key":"8011_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/eji.202048668","volume":"51","author":"V Valeri","year":"2021","unstructured":"Valeri, V. et al. Mast cells crosstalk with B cells in the gut and sustain IgA response in the inflamed intestine. Eur. J. Immunol. 51, 445\u2013458. https:\/\/doi.org\/10.1002\/eji.202048668 (2021).","journal-title":"Eur. J. Immunol."},{"key":"8011_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/cells8010078","volume":"8","author":"S Preisker","year":"2019","unstructured":"Preisker, S. et al. Crohn\u2019s disease patients in remission display an enhanced intestinal IgM+ B cell count in concert with a strong activation of the intestinal complement system. Cells 8, 78. https:\/\/doi.org\/10.3390\/cells8010078 (2019).","journal-title":"Cells"},{"key":"8011_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/1535-7163.Mct-13-0466","volume":"13","author":"Z Qin","year":"2014","unstructured":"Qin, Z. et al. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. Mol. Cancer Ther. 13, 154\u2013164. https:\/\/doi.org\/10.1158\/1535-7163.Mct-13-0466 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"8011_CR48","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.4049\/jimmunol.180.8.5335","volume":"180","author":"M Gohda","year":"2008","unstructured":"Gohda, M. et al. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer\u2019s patches for intestinal IgA responses. J. Immunol. 180, 5335\u20135343. https:\/\/doi.org\/10.4049\/jimmunol.180.8.5335 (2008).","journal-title":"J. Immunol."},{"key":"8011_CR49","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.dld.2019.03.020","volume":"51","author":"EK Kwong","year":"2019","unstructured":"Kwong, E. K. et al. The role of sphingosine kinase 2 in alcoholic liver disease. Dig. Liver Dis. 51, 1154\u20131163. https:\/\/doi.org\/10.1016\/j.dld.2019.03.020 (2019).","journal-title":"Dig. Liver Dis."},{"key":"8011_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/nyas.13360","volume":"1397","author":"V Garcia-Hernandez","year":"2017","unstructured":"Garcia-Hernandez, V., Quiros, M. & Nusrat, A. Intestinal epithelial claudins: Expression and regulation in homeostasis and inflammation. Ann. N. Y. Acad. Sci. 1397, 66\u201379. https:\/\/doi.org\/10.1111\/nyas.13360 (2017).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"8011_CR51","first-page":"663","volume":"16","author":"M Kim","year":"2006","unstructured":"Kim, M., Lee, S., Yang, S. K., Song, K. & Lee, I. Differential expression in histologically normal crypts of ulcerative colitis suggests primary crypt disorder. Oncol. Rep. 16, 663\u2013670 (2006).","journal-title":"Oncol. Rep."},{"key":"8011_CR52","doi-asserted-by":"publisher","first-page":"110372","DOI":"10.1016\/j.ecoenv.2020.110372","volume":"193","author":"L Miao","year":"2020","unstructured":"Miao, L. et al. Alterations in cecal microbiota and intestinal barrier function of laying hens fed on fluoride supplemented diets. Ecotoxicol. Environ. Saf. 193, 110372. https:\/\/doi.org\/10.1016\/j.ecoenv.2020.110372 (2020).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"8011_CR53","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1053\/j.gastro.2011.10.025","volume":"142","author":"L Ding","year":"2012","unstructured":"Ding, L. et al. Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice. Gastroenterology 142, 305\u2013315. https:\/\/doi.org\/10.1053\/j.gastro.2011.10.025 (2012).","journal-title":"Gastroenterology"},{"key":"8011_CR54","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/jcbfm.2012.3","volume":"32","author":"BK Wacker","year":"2012","unstructured":"Wacker, B. K., Freie, A. B., Perfater, J. L. & Gidday, J. M. Junctional protein regulation by sphingosine kinase 2 contributes to blood-brain barrier protection in hypoxic preconditioning-induced cerebral ischemic tolerance. J. Cereb. Blood Flow Metab. 32, 1014\u20131023. https:\/\/doi.org\/10.1038\/jcbfm.2012.3 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"8011_CR55","doi-asserted-by":"publisher","first-page":"e113998","DOI":"10.1371\/journal.pone.0113998","volume":"9","author":"AJ Snider","year":"2014","unstructured":"Snider, A. J. et al. Distinct roles for hematopoietic and extra-hematopoietic sphingosine kinase-1 in inflammatory bowel disease. PLoS ONE 9, e113998. https:\/\/doi.org\/10.1371\/journal.pone.0113998 (2014).","journal-title":"PLoS ONE"},{"key":"8011_CR56","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1128\/mcb.25.24.11113-11121.2005","volume":"25","author":"K Mizugishi","year":"2005","unstructured":"Mizugishi, K. et al. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25, 11113\u201311121. https:\/\/doi.org\/10.1128\/mcb.25.24.11113-11121.2005 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"8011_CR57","first-page":"4557","volume":"7","author":"U Erben","year":"2014","unstructured":"Erben, U. et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int. J. Clin. Exp. Pathol. 7, 4557\u20134576 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"8011_CR58","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1111\/bph.14501","volume":"175","author":"M Ant\u00f3n","year":"2018","unstructured":"Ant\u00f3n, M. et al. Alcohol binge disrupts the rat intestinal barrier: The partial protective role of oleoylethanolamide. Br. J. Pharmacol. 175, 4464\u20134479. https:\/\/doi.org\/10.1111\/bph.14501 (2018).","journal-title":"Br. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08011-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T23:40:13Z","timestamp":1669333213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08011-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8011"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08011-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4073"}}